Xiaoling Fu
Impact in
-
- Pharmacological Effects of Natural Compounds
Papers in
- Oncology 6
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Hua Sui (3 shared papers)Qi Li (3 shared papers)Huirong Zhu (3 shared papers)Zhe‐Sheng Chen (2 shared papers)Jianping Huang (1 shared paper)Huayue Zhang (1 shared paper)Lihong Zhou (2 shared papers)Yali Zhang (1 shared paper)
- Journals
- Journal of Cellular Biochemistry (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Recent Patents on Anti-Cancer Drug Discovery (1 paper)Cancer Management and Research (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Xiaoling Fu
21 papers receiving 267 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 21
- Cancer Research 34
- Oncology 53
- Molecular Biology 104
- Pharmacology 24
Countries citing papers authored by Xiaoling Fu
This map shows the geographic impact of Xiaoling Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Fu more than expected).
Fields of papers citing papers by Xiaoling Fu
This network shows the impact of papers produced by Xiaoling Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Fu. The network helps show where Xiaoling Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 55 | |
| 2 | 2014 | 51 | |
| 3 | 2023 | 26 | |
| 4 | 2015 | 21 | |
| 5 | 2014 | 17 | |
| 6 | 2020 | 16 | |
| 7 | 2021 | 13 | |
| 8 | 2017 | 12 | |
| 9 | 2016 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2017 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2020 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2023 | 1 |
About Xiaoling Fu
Xiaoling Fu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Artificial Intelligence and Surgery, having authored 21 papers that have together received 269 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Law, AI, and Intellectual Property (2 papers), Soil Carbon and Nitrogen Dynamics (1 paper), Connective tissue disorders research (1 paper), Quinazolinone synthesis and applications (1 paper), Natural Compounds in Disease Treatment (1 paper), Hemoglobinopathies and Related Disorders (1 paper) and Food Quality and Safety Studies (1 paper). The work is most often cited by research in Pharmacology (21 citations), Cancer Research (34 citations), Oncology (53 citations), Molecular Biology (104 citations) and Pharmacology (24 citations). Xiaoling Fu has collaborated with scholars based in China, United States and India. Frequent co-authors include Hua Sui, Qi Li, Huirong Zhu, Zhe‐Sheng Chen, Jianping Huang, Huayue Zhang, Lihong Zhou, Yali Zhang, Xuan Liu and Wanli Deng. Their work appears in journals such as Journal of Cellular Biochemistry, Frontiers in Cell and Developmental Biology, Recent Patents on Anti-Cancer Drug Discovery, Cancer Management and Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.